Next Article in Journal
Compact Heat Integrated Reactor System of Steam Reformer, Shift Reactor and Combustor for Hydrogen Production from Ethanol
Next Article in Special Issue
Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation
Previous Article in Journal
Iron Oxide/Salicylic Acid Nanoparticles as Potential Therapy for B16F10 Melanoma Transplanted on the Chick Chorioallantoic Membrane
Previous Article in Special Issue
A Mini-Review: Needleless Electrospinning of Nanofibers for Pharmaceutical and Biomedical Applications
Open AccessFeature PaperArticle

Fabrication of Biopolymer Based Nanoparticles for the Entrapment of Chromium and Iron Supplements

The School of Pharmacy, University of Reading, Reading RG6 6AD, UK
Faculty of Science & Technology, University of Westminster, 115 New Cavendish Street, London W1W 6UW, UK
Author to whom correspondence should be addressed.
Processes 2020, 8(6), 707;
Received: 20 May 2020 / Revised: 8 June 2020 / Accepted: 15 June 2020 / Published: 19 June 2020
The objective of this study was to encapsulate iron and chromium into novel nanoparticles formulated using chitosan (CS), dextran sulfate (DS) and whey protein isolate (WPI) for oral drug delivery. Empty and loaded CS-DS nanoparticles were prepared via complex coacervation whilst whey protein nanocarriers were produced by a modified thermal processing method using chitosan. The physiochemical properties of the particles were characterized to determine the effects of formulation variables, including biopolymer ratio on particle size and zeta potential. Permeability studies were also undertaken on the most stable whey protein–iron nanoparticles by measuring Caco-2 ferritin formation. A particle size analysis revealed that the majority of samples were sub-micron sized, ranging from 420–2400 nm for CS-DS particles and 220–1000 nm for WPI-CS samples. As expected, a higher chitosan concentration conferred a 17% more positive zeta potential on chromium-entrapped WPI nanoparticles, whilst a higher dextran volume decreased the size of CS-DS nanoparticles by 32%. The addition of iron also caused a significant increase in size for all samples, as seen where the loaded WPI samples were 296 nm larger than the empty particles. Caco-2 iron absorption revealed that one formulation, which had the lowest particle size (226 ± 10 nm), caused a 64% greater iron absorption compared to the ferrous sulfate standard. This study describes, for the first time, the novel design of chromium- and iron-entrapped nanoparticles, which could act as novel systems for oral drug delivery. View Full-Text
Keywords: iron; chromium; whey protein isolate; nanoparticles; oral drug delivery iron; chromium; whey protein isolate; nanoparticles; oral drug delivery
Show Figures

Figure 1

MDPI and ACS Style

Patel, N.; Zariwala, M.G.; Al-Obaidi, H. Fabrication of Biopolymer Based Nanoparticles for the Entrapment of Chromium and Iron Supplements. Processes 2020, 8, 707.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop